The query space is now infinite. What that means for how brands build authority, earn selection by AI systems, and rethink search strategy.

An open source project called Scrapling is gaining traction with AI agent users who want their bots to scrape sites without permission.

Tao: Today there are a lot of very tedious types of mathematics that we don’t like doing, so we look for clever ways to get ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to buy according to analysts. On December 19, TheFly reported that Cathie Wood’s ARK Investment has ...

Has "67" reached its peak? Google added it as an Easter egg in the search engine. The new slang term spiked with Generation Alpha and Gen Z this year. Dictionary.com named "6-7" its 2025 Word of the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...